9 ETFs At The Forefront Of 2019 Market Rally

The Wall Street has witnessed an astounding run this year, braving all the woes including recession fears, geopolitical tensions, U.S.-Sino trade spat and talks of Trump impeachment. Notably, all three major indices are hitting record highs. In fact, the S&P 500 breached the 3,200 level for the first time ever this month while the Dow Jones topped the 28,000 milestones last month. Meanwhile, Nasdaq also went past the 9000 level.

The rally was powered by upbeat data across the globe, easing monetary policies, stronger-than-expected earnings and positive developments in trade. The U.S. economy is on a strong growth path with job additions at the fastest pace this year and unemployment dropping to the lowest level since 1969. The housing market is also clearly showing signs of a strong recovery with lower mortgage rates and slower home price growth acting as catalysts.

Internationally, the latest update from China shows that acceleration of industrial output and retail sales growth in November bolstered investors’ confidence. Meanwhile, Japan's economy expanded more rapidly than initially reported in the third quarter.

Notably, the initial phase-one trade deal reached between Washington and Beijing has abated fears of global growth concerns lending strong optimism in the stock market.

As there have been winners in many corners of the space, we highlight nine ETFs from different zones that have outperformed so far this year. These are expected to continue outperforming, provided the fundamentals remain intact.

Virtus LifeSci Biotech Clinical Trials ETF (BBC - Free Report) — Up 70.5%

This ETF has a novel approach to biotechnology investing with exposure to companies that are in the clinical trial stage by tracking the LifeSci Biotechnology Clinical Trials Index. It has amassed $41.6 million in its asset base and charges 79 bps in fees per year from investors. The product holds 96 securities in its basket and carries a Zacks ETF Rank #3 (Hold) with a High risk outlook.

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.